Last $74.71 USD
Change Today +3.71 / 5.23%
Volume 1.6M
BMRN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard E. Post Ph.D.

Chief Scientific Officer and Vice President of Research, BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 45 board members in 5 different organizations across 9 different industries.

See Board Relationships
61--

Background*

Dr. Leonard E. Post, also known as Len, Ph.D serves as an Life Sciences Advisor at CM Capital Investments Pty Ltd since 2006. Previously, he was an Executive Advisor at the firm. He provides advice and expertise in drug and clinical development. Dr. Post serves as the Chief Scientific Officer at BioMarin Pharmaceuticals Inc. He serves as a Scientific Advisor of Ambit Biosciences Corporation. He has over 30 years of experience in all stages of pharmaceutical and biotechnology ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

Chairman of Scientific Advisory Board and Director
Director
Former Chief Scientific Officer and Director
Director
2003-N/A
Former Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2007-N/A
Former Director and Consultant
2011-Present
Non-Executive Director and Member of the Remuneration & Nominations Committee

Education*

PhD
University of Wisconsin - Madison
Post-Doctoral Training
The University of Chicago
BS
University of Michigan

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $74.71 USD +3.71

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
W. Thomas Amick Chief Executive Officer, President and Director
Dendreon Corp.
--
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.